iOmx
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Fraunhoferstrasse 13, Martinsried/ Munic...Phone Number
+49 89899970900Website
www.iomx.comRevenue
$5.8 MillionIndustry
About iOmx
Is iOmx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if iOmx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
iOmx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if iOmx had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at iOmx
Website visits: Recent activity has been detected on your website
Check if iOmx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once iOmx has new funding data
Earning: See what the market has to say on iOmx recently announced quarterly report
Product Launch: Get notified when iOmx launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
iOmx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
iOmx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about iOmx.
iOmx financials insights
Gather financial insights about iOmx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$44.6M
Series B
$75.4M
iOmx Tech Stack
A closer look at the technologies used by iOmx
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding iOmx
iOmx Therapeutics, located in Martinsried, Germany, is a biopharmaceutical company focused on developing first-in-class cancer immuno-therapeutics addressing novel immune checkpoints hijacked by cancer cells.... Read More